Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-166.96%
operating margin TTM
-167.96%
revenue TTM
4.62 Million
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -2.88 |
| peg ratio | -0.22 |
| price to book ratio | 3.08 |
| price to sales ratio | 7.49 |
| enterprise value multiple | -5.00 |
| price fair value | 3.08 |
profitability ratios | |
|---|---|
| gross profit margin | 99.27% |
| operating profit margin | -167.96% |
| pretax profit margin | -166.96% |
| net profit margin | -166.96% |
| return on assets | -54.28% |
| return on equity | -137.99% |
| return on capital employed | -63.2% |
liquidity ratios | |
|---|---|
| current ratio | 7.03 |
| quick ratio | 7.01 |
| cash ratio | 2.07 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 424.81 |
| operating cycle | 425.75 |
| days of payables outstanding | 9,681.70 |
| cash conversion cycle | -9,255.95 |
| receivables turnover | 389.57 |
| payables turnover | 0.04 |
| inventory turnover | 0.86 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | -66.95 |
| cash flow to debt ratio | -35.98 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.43 |
| cash per share | 2.46 |
| operating cash flow per share | -1.42 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -35.98 |
| short term coverage ratios | -69.45 |
| capital expenditure coverage ratio | -97.17 |
Frequently Asked Questions
When was the last time Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) reported earnings?
Orchestra BioMed Holdings, Inc. (OBIO) published its most recent earnings results on 12-05-2026.
What is Orchestra BioMed Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)'s trailing twelve months ROE is -137.99%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Orchestra BioMed Holdings, Inc. (OBIO) currently has a ROA of -54.28%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OBIO's net profit margin stand at?
OBIO reported a profit margin of -166.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OBIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.03 in the most recent quarter. The quick ratio stood at 7.01, with a Debt/Eq ratio of 0.03.